Dermatologist's Take
Tacrolimus ointment is a strong steroid-free choice for eczema on the face and eyelids, where it calms inflammation without thinning the skin. The main downsides are early burning or stinging and a boxed warning about a possible cancer risk that real-world use has not confirmed. It controls flares but does not cure eczema.
At a glance
- AKA: Protopic (brand name)
- Drug Class: Topical calcineurin inhibitor (a non-steroid anti-inflammatory)
- Rx or OTC: Prescription only (Rx)
- Typical Strength/Dose: Ointment in 0.03% and 0.1%; a thin layer twice a day
- Time to Work: Itch often eases within about a week; full effect over a few weeks
- Evidence Level: Strong. It is a well-studied, FDA-approved second-line treatment for eczema.
- Important: Carries an FDA boxed warning about a possible cancer risk. Real-world use has not proven this link, but it is used as second-line and not continuously.
What is it?
What is it text.
How it works
Tacrolimus blocks a protein called calcineurin inside immune cells called T cells. These cells help drive the inflammation behind eczema. By quieting them, tacrolimus lowers redness, swelling, and itch. Because it is not a steroid, it does not thin the skin, which is why it is useful on the face and eyelids.
How it's typically used
Tacrolimus comes as an ointment in two strengths: 0.03% and 0.1%. Adults may use either strength. For children ages 2 and older, only the 0.03% strength is approved. It is not approved for children under 2.
A thin layer is usually rubbed into the affected skin twice a day. It is used as a second-line treatment, meaning it is often tried when steroids have not worked well or are not a good choice, such as on the face or eyelids. It is meant for short-term and on-and-off use, not nonstop daily use for months on end. Because sunlight can interact with the medicine, limit sun exposure and use sun protection on treated skin.
Common side effects
- Burning, stinging, or warmth at the application site, especially in the first few days
- Itching
- Redness
- Flushing or skin warmth after drinking alcohol
- Cold or flu-like symptoms
The burning and stinging usually fade as the skin heals over the first week or so.
Serious side effects
Call your doctor if you notice:
- Signs of skin infection — spreading redness, pus, cold sores, or a widespread herpes rash. Calcineurin inhibitors can make some skin infections more likely.
- Swollen glands (lymph nodes) that do not go away
- New or changing skin growths on treated areas
- Severe or lasting burning that does not improve after the first week
About the boxed warning: the FDA added a warning about a possible risk of cancer, such as skin cancer or lymphoma, based on animal studies and rare reports. Large real-world studies have not shown that the ointment causes cancer. To stay safe, it is used as second-line, on the smallest area needed, and not continuously.
Who shouldn't take it
- People with a known allergy to tacrolimus or any ingredient in the ointment
- Not approved for children under 2 years old
- People with a weakened immune system (immunocompromised), unless a specialist advises it
- Use caution on skin with an active infection, and treat the infection first
- Netherton syndrome or widely broken skin barriers, where more of the drug can absorb
